Sodium Oxybate: A Review of Its Use in Alcohol Withdrawal Syndrome and in the Maintenance of Abstinence in Alcohol Dependence

@article{Keating2013SodiumOA,
  title={Sodium Oxybate: A Review of Its Use in Alcohol Withdrawal Syndrome and in the Maintenance of Abstinence in Alcohol Dependence},
  author={G. Keating},
  journal={Clinical Drug Investigation},
  year={2013},
  volume={34},
  pages={63-80}
}
  • G. Keating
  • Published 2013
  • Medicine
  • Clinical Drug Investigation
  • A liquid formulation of sodium oxybate (Alcover®), the sodium salt of γ-hydroxybutyric acid (GHB), is approved in Italy and Austria for use in alcohol withdrawal syndrome and for the maintenance of abstinence in alcohol dependence. This article reviews the efficacy and tolerability of sodium oxybate in alcohol withdrawal syndrome and in the maintenance of abstinence in alcohol dependence, as well as summarizing its pharmacological properties. Results of randomized controlled trials indicate… CONTINUE READING
    53 Citations

    Paper Mentions

    Interventional Clinical Trial
    The purpose of this study is to determine whether gamma-Hydroxybutyrate (GHB) has prosocial and prosexual effects in healthy male participants, and to characterize these putative… Expand
    ConditionsAutistic Disorder, Bipolar Disorder, Depressive Disorder, Major
    InterventionDrug
    A Brief Up-Date of the Use of Sodium Oxybate for the Treatment of Alcohol Use Disorder
    • 17
    • Highly Influenced
    • PDF
    Sodium oxybate plus nalmefene for the treatment of alcohol use disorder: A case series
    • 4
    • Highly Influenced
    Clinical applications of sodium oxybate (GHB): from narcolepsy to alcohol withdrawal syndrome.
    • 25
    • PDF
    Alcohol Withdrawal Syndrome: Benzodiazepines and Beyond.
    • 54
    • PDF
    Inpatient Management of Acute Alcohol Withdrawal Syndrome
    • 72
    • Highly Influenced
    Pharmacotherapeutic management of acute alcohol withdrawal syndrome in critically Ill patients

    References

    SHOWING 1-10 OF 81 REFERENCES
    Sodium oxybate in maintaining alcohol abstinence in alcoholic patients with and without psychiatric comorbidity
    • 21
    • Highly Influential
    Sodium oxybate in maintaining alcohol abstinence in alcoholic patients according to Lesch typologies: A pilot study
    • 12
    • Highly Influential
    New developments for the pharmacological treatment of alcohol withdrawal syndrome. A focus on non-benzodiazepine GABAergic medications
    • 91
    • Highly Influential
    Substitution therapy for alcoholism: time for a reappraisal?
    • 59
    • Highly Influential
    Nalmefene: A Review of Its Use in the Treatment of Alcohol Dependence
    • 48
    Gamma-hydroxybutyric acid (GHB) in the treatment of alcohol withdrawal syndrome: a randomized comparative study versus benzodiazepine.
    • 104
    • Highly Influential
    Gamma-hydroxybutyric acid versus naltrexone in maintaining alcohol abstinence: an open randomized comparative study.
    • 71
    • Highly Influential
    Gamma-hydroxybutyrate (GHB) for treatment of alcohol withdrawal and prevention of relapses.
    • 118